The first product from #AbbVie's $8.7 billion takeover of #Cerevel two years ago – #Parkinsonsdisease therapy #tavapadon – has been approved by the #FDA.
@pharmaphorum.bsky.social
@pharmaphorum.bsky.social
@pharmaphorum.bsky.socialThe first product from #AbbVie's $8.7 billion takeover of #Cerevel two years ago – #Parkinsonsdisease therapy #tavapadon – has been approved by the #FDA.